Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
Journal of Investigative Dermatology - United Kingdom
doi 10.1038/jid.2014.512
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2015
Authors
Publisher
Elsevier BV